<transcy>Nouvelles</transcy>
HYTN Innovations expands its Controlled Drugs and Substances Dealers License to include MDMA and Ketamine
VANCOUVER, British Columbia, HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN), a Vancouver-based...
HYTN Innovations Cultivates Psilocybin Mushrooms and Upgrades Equipment for API Development
Vancouver, British Columbia - HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) announced that...
HYTN Innovations Advances Active Pharmaceutical Ingredient Portfolio and Increases Sales of Rapid Onset Cannabis Products Using Proprietary Elevation Technology
Vancouver, British Columbia - HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN), a leading...
HYTN Sells Out of Innovative Holiday Products
Vancouver, British Columbia. HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) announces that its...
HYTN Initiates Sale of Cannabis Products in Quebec Through Agreement With Rose
Vancouver, British Columbia. HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) is pleased to...
HYTN Awarded Controlled Drugs and Substances Dealer’s License Allowing for Production and Sale of Psilocybin
October 17, 2022 - Vancouver, British Columbia. HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE:...
HYTN Opens Provincial and Territorial Markets for Tricanna Manufactured Pre-Rolled Cannabis Products
Vancouver, British Columbia. HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) is pleased to...
HYTN Awarded Medical Cannabis Sales Licence Increasing Opportunities at Kelowna Facility
Vancouver, British Columbia. HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) is pleased to...
